CD4 + T-lymphocyte-specific Hepatitis C virus-epitopes

Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C424S185100, C424S186100, C424S189100, C424S204100, C514S002600, C530S300000, C530S328000, C435S005000, C435S007100

Reexamination Certificate

active

07108856

ABSTRACT:
The invention relates to Hepatitis C virus epitopes which are specific in relation to CD4+ T lymphocytes, in addition to vaccinations which contain said epitopes.

REFERENCES:
patent: 5709995 (1998-01-01), Chisari et al.
patent: 2004/0091995 (2004-05-01), Schlom et al.
patent: WO 01/24822 (2001-04-01), None
patent: 7-285994 (1995-10-01), None
patent: WO 93/06247 (1993-04-01), None
patent: WO 94/13699 (1994-06-01), None
patent: WO 94/20127 (1994-09-01), None
patent: WO 95/22317 (1995-08-01), None
patent: WO 98/32456 (1998-07-01), None
patent: WO 99/02183 (1999-01-01), None
patent: WO 99/45954 (1999-09-01), None
patent: WO 99/58658 (1999-11-01), None
Rollier et al., Journal of Virology, vol. 78 No. 1, pp. 187-196 (Jan. 2004).
Heile et al., Journal of Virology, vol. 74 No. 15, pp. 6885-6892 (Aug. 2000).
Koziel et al., Journal of Virology, vol. 67 No. 12, pp. 7522-7532 (Dec. 1993).
Lazdina et al., Journal of General Virology, vol. 82, pp. 1299-1308 (2001).
Definitions of “medicament,” “medicinal,” and “vaccine”, The On-line Medical Dictionary, cancerweb.ncl.ac.uk/omd/.
Ruppert et al., Proceeding of the National Academy of Sciences, USA, vol. 90, pp. 2671-2675 (1993).
Diepolder et al., Journal of Virology, vol. 75 No. 17, pp. 7803-7810 (2001).
Deveraux et al., Journal of General Virology, vol. 78, pp. 583-590 (1997).
Alexander et al., Human Immunology, vol. 59 No. 12, pp. 776-782 (Dec. 1998).
Chang et al., Journal of Clinical Investigation, vol. 100 No. 9, pp. 2376-2385 (Nov. 1997).
Choo et al., Proceeding of the National Academy of Sciences, vol. 88 No. 6, pp. 2451-2455 (Mar. 1991).
Fan et al., APMIS, vol. 108 Nos. 7-8, pp. 531-538 (Jul.-Aug. 2000).
Derwent Publications Ltd., London, GB, English language abstract of JP 7-285994, “Synthetic peptide(s) with high reactivity to serum from patient with hepatitis C virus—used for diagnosis of HCV infection.” 1995.
Tanaka et al., 1992 Virus Research 23: 39-53.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

CD4 + T-lymphocyte-specific Hepatitis C virus-epitopes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with CD4 + T-lymphocyte-specific Hepatitis C virus-epitopes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and CD4 + T-lymphocyte-specific Hepatitis C virus-epitopes will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3581696

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.